Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date: December 31, 1981
Sector: Healthcare
Industry: Pharma
Market Cap: $94.49B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.41 | 0.92%
Avg Daily Range (30 D): $0.52 | 1.09%
Avg Daily Range (90 D): $0.68 | 1.33%
Institutional Daily Volume
Avg Daily Volume: 9.38M
Avg Daily Volume (30 D): 9.98M
Avg Daily Volume (90 D): 11M
Trade Size
Avg Trade Size (Sh.): 182
Avg Trade Size (Sh.) (30 D): 108
Avg Trade Size (Sh.) (90 D): 102
Institutional Trades
Total Inst.Trades: 123,868
Avg Inst. Trade: $4.94M
Avg Inst. Trade (30 D): $7.02M
Avg Inst. Trade (90 D): $6.61M
Avg Inst. Trade Volume: .11M
Avg Inst. Trades (Per Day): 22
Market Closing Trades
Avg Closing Trade: $58.1M
Avg Closing Trade (30 D): $112.91M
Avg Closing Trade (90 D): $121.49M
Avg Closing Volume: 1.08M
   
News
Jul 23, 2025 @ 4:51 PM
Rheumatologists Eye AbbVie’s Rinvoq, Roche/...
Source: Spherix Global Insights
Jul 22, 2025 @ 5:00 PM
Melanoma Market Anticipates a Dynamic Shift During...
Source: Delveinsight
Jul 18, 2025 @ 5:54 PM
Bristol Myers' Drug Flunks Blood Cancer-Associated...
Source: Vandana Singh
Jul 16, 2025 @ 11:00 AM
As Excitement Builds for HR Tech 2025, HR Executiv...
Source: Elizabeth Clarke
Jul 16, 2025 @ 8:25 AM
3 Reasons the Schwab U.S. Dividend Equity ETF Is a...
Source: Justin Pope
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $2.69 $1.21 $.04
Diluted EPS $2.68 $1.2 $.04
Revenue $ 47.64B $ 11.2B $ 12.34B
Gross Profit $ 33.57B $ 8.17B $ 7.53B
Net Income / Loss $ 5.44B $ 2.46B $ 76M
Operating Income / Loss $ 6.11B $ 2.97B $ 175M
Cost of Revenue $ 14.07B $ 3.03B $ 4.81B
Net Cash Flow $ 1.54B $ 528M $ 2.45B
PE Ratio 18.33